Rfg Advisory, LLC Pfizer Inc Transaction History

Rfg Advisory, LLC

$3.18 Billion
Q3 2024

A detailed history of Rfg Advisory, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Rfg Advisory, LLC holds 56,130 shares of PFE stock, worth $1.47 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

56,130

Previous 66,463 15.55%

Holding current value

$1.47 Million

Previous $1.86 Million 12.64%

% of portfolio

0.05%

Previous 0.06%

34 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$27.7 - $31.39 $286,224 - $324,352	-10,333 Reduced 15.55%	56,130 $1.62 Million
Q2 2024 Jul 15, 2024	SELL	$25.26 - $29.6 $904,712 - $1.06 Million	-35,816 Reduced 35.02%	66,463 $1.86 Million
Q1 2024 Apr 11, 2024	BUY	$25.89 - $29.73 $1.16 Million - $1.33 Million	44,703 Added 77.64%	102,279 $2.84 Million
Q4 2023 Jan 25, 2024	SELL	$26.13 - $33.94 $192,264 - $249,730	-7,358 Reduced 11.33%	57,576 $1.66 Million
Q3 2023 Oct 16, 2023	SELL	$32.09 - $37.51 $416,688 - $487,067	-12,985 Reduced 16.66%	64,934 $2.15 Million
Q2 2023 Aug 03, 2023	BUY	$36.12 - $41.79 $120,785 - $139,745	3,344 Added 4.48%	77,919 $2.86 Million
Q1 2023 May 09, 2023	SELL	$39.39 - $51.28 $171,385 - $223,119	-4,351 Reduced 5.51%	74,575 $3.04 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $13,527 - $17,658	324 Added 0.41%	78,926 $4.05 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $244,705 - $298,724	5,592 Added 7.66%	78,602 $3.72 Million
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $997,184 - $1.18 Million	21,431 Added 41.55%	73,010 $3.6 Million
Q1 2022 May 11, 2022	SELL	$45.75 - $56.69 $71,919 - $89,116	-1,572 Reduced 2.96%	51,579 $2.67 Million
Q4 2021 Feb 02, 2022	BUY	$41.32 - $61.25 $281,265 - $416,928	6,807 Added 14.69%	53,151 $3.14 Million
Q3 2021 Oct 19, 2021	BUY	$39.25 - $50.42 $28,495 - $36,604	726 Added 1.59%	46,344 $1.99 Million
Q2 2021 Jul 29, 2021	BUY	$35.91 - $40.68 $22,695 - $25,709	632 Added 1.4%	45,618 $1.79 Million
Q1 2021 Apr 19, 2021	SELL	$33.49 - $37.77 $24,581 - $27,723	-734 Reduced 1.61%	44,986 $1.63 Million
Q4 2020 Feb 02, 2021	SELL	$33.47 - $42.56 $24,734 - $31,451	-739 Reduced 1.59%	45,720 $1.7 Million
Q3 2020 Oct 13, 2020	BUY	$31.75 - $37.25 $35,115 - $41,198	1,106 Added 2.44%	46,459 $1.71 Million
Q2 2020 Aug 03, 2020	BUY	$30.12 - $36.54 $49,788 - $60,400	1,653 Added 3.78%	45,353 $1.48 Million
Q1 2020 Apr 17, 2020	BUY	$27.03 - $38.62 $38,733 - $55,342	1,433 Added 3.39%	43,700 $1.43 Million
Q4 2019 Jan 22, 2020	BUY	$32.92 - $37.36 $66,893 - $75,915	2,032 Added 5.05%	42,267 $1.66 Million
Q3 2019 Nov 13, 2019	BUY	$32.49 - $42.13 $168,850 - $218,949	5,197 Added 14.83%	40,235 $1.45 Million
Q2 2019 Aug 23, 2019	BUY	$36.98 - $41.52 $948,573 - $1.07 Million	25,651 Added 273.26%	35,038 $1.52 Million
Q2 2019 Aug 15, 2019	SELL	$36.98 - $41.52 $601,701 - $675,571	-16,271 Reduced 63.41%	9,387 $404,000
Q1 2019 Apr 25, 2019	SELL	$37.5 - $41.2 $458,700 - $503,958	-12,232 Reduced 32.28%	25,658 $1.09 Million
Q4 2018 Feb 15, 2019	BUY	$38.47 - $43.86 $55,666 - $63,465	1,447 Added 3.97%	37,890 $1.65 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $240,910 - $292,210	6,989 Added 23.73%	36,443 $1.61 Million
Q2 2018 Jul 25, 2018	BUY	$32.98 - $35.16 $152,301 - $162,368	4,618 Added 18.59%	29,454 $1.07 Million
Q1 2018 May 10, 2018	SELL	$31.91 - $37.02 $2,297 - $2,665	-72 Reduced 0.29%	24,836 $881,000
Q4 2017 Feb 08, 2018	SELL	$33.26 - $35.29 $48,692 - $51,664	-1,464 Reduced 5.55%	24,908 $907,000
Q3 2017 Nov 02, 2017	BUY	$31.0 - $34.15 $14,601 - $16,084	471 Added 1.82%	26,372 $951,000
Q2 2017 Nov 01, 2017	BUY	N/A	153 Added 0.59%	25,901 $866,000
Q2 2017 Aug 14, 2017	BUY	N/A	48 Added 0.19%	25,748 $861,000
Q1 2017 Nov 01, 2017	BUY	N/A	8,835 Added 52.39%	25,700 $879,000
Q4 2016 Nov 01, 2017	BUY	N/A	16,865	16,865 $569,000

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.73B

Call Options Held

73.5M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $147B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rfg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rfg Advisory, LLC with notifications on news.

Account